Showing results (221-230 of 243) with videos related to

Sort By:
Pageof 25
ACS Nano|September 3, 2016
Atomic Layer Deposition Route To Tailor Nanoalloys of Noble and Non-noble MetalsRanjith K Ramachandran, Jolien Dendooven, Matthias Filez, et al.
Physical Chemistry Chemical Physics : PCCP|October 18, 2012
Synthesis, characterization and sorption properties of NH2-MIL-47Karen Leus, Sarah Couck, Matthias Vandichel, et al.
Atherosclerosis|September 11, 1998
The relationship between apolipoprotein E, dementia, and vascular illnessD B Marin, B Breuer, M L Marin, et al.
Sante (Montrouge, France)|April 21, 2007
[Epidemiology of epilepsy in sub-Saharan Africa: a review]E B Ngoungou, F Quet, C M Dubreuil, et al.
European Journal of Neurology|February 3, 2016
Evaluation of the application of the European guidelines for the diagnosis and clinical care of amyotrophic lateral sclerosis (ALS) patients in six French ALS centresB Marin, E Beghi, C Vial, et al.
Angewandte Chemie (International Ed. in English)|August 2, 2018
Kinetics of Lifetime Changes in Bimetallic Nanocatalysts Revealed by Quick X-ray Absorption SpectroscopyMatthias Filez, Hilde Poelman, Evgeniy A Redekop, et al.
Lung Cancer (Amsterdam, Netherlands)|August 2, 2014
Randomized open-label non-comparative multicenter phase II trial of sequential erlotinib and docetaxel versus docetaxel alone in patients with non-small-cell lung cancer after failure of first-line chemotherapy: GFPC 10.02 studyJ B Auliac, C Chouaid, L Greillier, et al.
Chemical Communications (Cambridge, England)|August 23, 2003
n-Alkane hydroconversion on Zeogrid and colloidal ZSM-5 assembled from aluminosilicate nanoslabs of MFI framework typeAlexander Aerts, Ward Huybrechts, Sebastien P B Kremer, et al.
Journal of Occupational and Environmental Medicine|August 5, 2025
Factors Influencing Perceived Mental Health Service Needs, Self-Reported Utilization, and Barriers to Care among Health System Faculty and StaffAysha Khan, Andrew Delgado, Hira Ali, et al.
Targeted Oncology|August 29, 2015
Impact of Continuing First-Line EGFR Tyrosine Kinase Inhibitor Therapy Beyond RECIST Disease Progression in Patients with Advanced EGFR-Mutated Non-Small-Cell Lung Cancer (NSCLC): Retrospective GFPC 04-13 StudyJ B Auliac, C Fournier, C Audigier Valette, et al.
Pageof 25